Inhibrx Biosciences
INBX
#6080
Rank
ยฃ0.77 B
Marketcap
ยฃ52.72
Share price
-7.21%
Change (1 day)
-17.75%
Change (1 year)

Inhibrx Biosciences (INBX) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : ยฃ0.15 Billion

According to Inhibrx Biosciences's latest financial reports the company's total liabilities are ยฃ0.15 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Inhibrx Biosciences - Total liabilities on balance sheet (from 2023 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31ยฃ0.10 B173.5%
2024-12-31ยฃ37.59 M-81.88%
2023-12-31ยฃ0.20 B948.51%
2022-12-31ยฃ19.79 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ORIC Pharmaceuticals
ORIC
ยฃ17.9 M-88.69%๐Ÿ‡บ๐Ÿ‡ธ USA